Consensus Valbiotis

Stocks

ALVAL

FR0013254851

Biotechnology & Medical Research

Market Closed - Euronext Paris 19:55:00 02/09/2026 +04			5-day change	1st Jan Change
0.7870 ^EUR	-1.50%		-5.18%	+13.40%

07-22	Valbiotis Publishes Results of Reverse-It Clinical Study Evaluating Totum 63 in Nature Communications	CI
06-29	Valbiotis Raises EUR10 Million for Commercial Development, Working Capital	MT

Evolution of the Average Target: Valbiotis

Evolution of the Target Price: Valbiotis

Changes in Analyst Recommendations: Valbiotis

48021cb92ac44181a58.0sVKzFOYYYrsPs4WsEhGgJ9vtP1VBY8afDA7bM6_Oo8.tfYQjyHTBeeJTYlb0yk11scd67dmTOd1Hn1MB_vKYNqNsjKrAdNMzq4LpQ~0e9d40350249330014daa8459483ca9f

Analysts' recommendations: Valbiotis

05-12	Valbiotis shares surge on Asian expansion plans
30/10/24	Valbiotis: Invest Securities reduces its target
17/07/23	Valbiotis: Invest Securities confirms its recommendation
25/05/23	Valbiotis: Oddo BHF raises its target price
23/05/23	Valbiotis: promising study, Invest Sec. raises its target
28/04/22	Valbiotis Announces First Visit of the First Patient in the TOTUM•63 Mode of Action Clinical Study Conducted by the INAF, in Partnership With Nestlé Health Science	CI

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	VALBIOTIS			-	-	+125.28%
	WUXI APPTEC CO., LTD.					+19.12%
	ARGENX SE					+11.09%
	INSMED INCORPORATED					+64.75%
	BIONTECH SE					+18.05%
	GENMAB A/S					+13.05%
	PHARMAESSENTIA CORPORATION					+6.66%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+26.26%
	EXELIXIS, INC.					-5.63%
	MADRIGAL PHARMACEUTICALS, INC.					+25.87%
	Average					+30.45%
	Weighted average by Cap.					+19.79%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7870EUR

Average target price

1.800EUR

Spread / Average Target

+128.72%

High Price Target

1.800EUR

Spread / Highest target

+128.72%

Low Price Target

1.800EUR

Spread / Lowest Target

+128.72%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
ALVAL Stock
Consensus Valbiotis

As early as today, start finding the best investment opportunities!